The VENTANA PD-L1 (SP142) Assay was approved as a complementary diagnostic for Tecentriq immunotherapy.
The Zika virus may spread into Europe as the weather gets warmer, although the risk is low, health officials said.
Oramed Pharmaceuticals’ experimental oral insulin succeeded in significantly reducing night-time blood glucose in a midstage trial.
Novartis split its pharmaceuticals division into two separate business units focused on drug development and cancer.
MacroGenics Enters Collaboration and License Agreement with Janssen to Develop New DART Molecule for the Treatment of Cancer.
Cambridge, Massachusetts-based Agios Pharmaceuticals inked a new global collaboration deal with Summit, New Jersey-based Celgene.
A clinical trial testing an experimental breast cancer pill from Novartis has been stopped early because of good results, boosting the Swiss company’s efforts to build up its oncology business.
AstraZeneca’s recently approved ovarian cancer drug Lynparza failed to increase overall survival significantly when given with chemotherapy to patients with gastric cancer in a late-stage trial, the drugmaker said .
Coherus BioSciences said the U.S. Patent and Trademark office agreed to review its petition to make a copy of AbbVie’s top-selling arthritis drug Humira.
Redwood City, California-based Relypsa disclosed prescription sales information for Veltassa that led to a stock decline of 7.8 percent.
Catalyst Pharmaceuticals is slashing its workforce by about 30 percent in an effort to conserve capital and save its investigational drug program for the treatment of LEMS and CMS.
AstraZeneca’s drive to rebuild its portfolio of new medicines received a boost with positive results for an experimental biotech drug for severe asthma that the company previously flagged as a potential $2 billion-a-year seller.
Pfizer Inc’s purchase of Anacor Pharmaceuticals Inc heralds an approaching wave of potentially safer and more effective treatments for millions who suffer from eczema, a common skin condition that causes infection-prone rashes that can feel like having poison ivy 24 hours a day.
A white paper from Aesica, a leading pharmaceutical contract development and manufacturing organization (CDMO) for both APIs and finished dosage forms. Serialization has emerged as a complex challenge for the pharmaceuticals sector,, which is facing a multiplicity of differing regulations that vary from one country to another. Several countries including China, South Korea, Turkey, […]
Webinar: Career Conversation 11 – Conflict Management Tue, Jun 7, 2016 12:00 PM – 1:15 PM How do you keep your professional “cool” when conversing with an irrational person? Join us for the 11th program in the Career Conversations webinar series to learn how. Event Time Zone: Eastern Time Event Type: Program […]
A federal agency released final rules on how employers can offer workers financial incentives of up to 30 percent of the cost of their cheapest health insurance plans to participate in wellness programs without violating federal laws protecting the confidentiality of medical information.
Republicans in the U.S. House of Representatives will try to pass legislation this week providing $622.1 million in funds to fight the spreading Zika virus, far less than the Obama administration has been seeking.
Omnicom Public Relations Group, part of Omnicom Group Inc. (NYSE: OMC), today announced the acquisition of Rabin Martin, an innovative global health strategy consulting firm.
Valeant will raise the discounts to hospitals on its heart drugs Nitropress and Isuprel to as much as 40 percent off list prices.
Egypt is raising the price cap on medicines that cost up to 30 Egyptian pounds ($3.38) by 20 percent in an effort to address drug shortages, the health minister said.